RECRUITING

Text-Messaging Telehealth and Contingency Management for Opioid Use Disorder Treatment Engagement

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

There is growing recognition of the need for approaches to initiate treatment wherever patients touch the health care system, including the Emergency Department (ED). Most research has focused on initiation of medications for opioid use disorder (MOUDs) in the ED rather than ensuring continued treatment post-discharge. The investigators propose to adapt evidence-based interventions to support patients' complex needs and facilitate continued treatment, rather than discharging them and having them navigate outpatient treatment systems with limited support. The research team will randomize participants into 1 of 4 arms to receive varying degrees of augmented usual care, including daily check-ins and contingency management. The investigators plan to examine the effects of check-ins and contingency management on engagement with addiction treatment and equity of treatment effects among racial and ethnic subgroups and assess important moderators of treatment effects.

Official Title

Text-Messaging Telehealth and Contingency Management for Opioid Use Disorder Treatment Engagement

Quick Facts

Study Start:2024-03-20
Study Completion:2026-07-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05897788

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Participants must be 18 or older
  2. * Screen positive for OUD
  3. * Bridge buprenorphine prescription (emergency department (ED) enrollment - Buprenorphine prescription at ED discharge; Bridge clinic enrollment - new buprenorphine prescription associated with on-demand or drop-in encounter
  4. * English reading ability
  5. * Have a mobile phone capable of receiving text messages
  1. * Not being up to date with requirements above

Contacts and Locations

Study Contact

Dina Abdel-Rahman, BS,
CONTACT
609-248-0229
dina.abdel-rahman@pennmedicine.upenn.edu

Principal Investigator

Kit Delgado, MD, MS
PRINCIPAL_INVESTIGATOR
University of Pennsylvania

Study Locations (Sites)

University of Pennsylvania
Philadelphia, Pennsylvania, 19104
United States

Collaborators and Investigators

Sponsor: University of Pennsylvania

  • Kit Delgado, MD, MS, PRINCIPAL_INVESTIGATOR, University of Pennsylvania

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-03-20
Study Completion Date2026-07-30

Study Record Updates

Study Start Date2024-03-20
Study Completion Date2026-07-30

Terms related to this study

Keywords Provided by Researchers

  • Opioid use disorder
  • Contingency Management
  • text-based interventions

Additional Relevant MeSH Terms

  • Opioid Use Disorder
  • Opioid Dependence with Current Use (Disorder)